Skip to main content

Risk-Adapted, Combined-Modality Therapy for Unfavorable Pediatric Hodgkin Lymphom

Research Abstract
Background and Objectives: Risk-adapted therapy for children with HL is directed toward high survival, minimal toxicity and optimal quality of life, with long term follow up. We assess the impact of prognostic factors associated with local treatment failure of pediatric HL patients with unfavorable criteria treated with combined modality: Alternating ABVD (Doxorubicin, Bleomycin, Vinblastine and Decarbazine) and COEP (Cyclophosphamide, Oncovin, Etoposide and Prednisone) chemotherapy and response-based, involved-field radiation for newly diagnosed unfavorable pediatric HL patients, also will detect toxicities and long-term complications observed in the patients. Methods: This prospective study was carried out from January 2010 to January 2018, with a median follow up of 74 months (range 8 - 103 months). 54 patients were eligible for this study stratified into two groups: intermediate risk (IR) and high-risk group (HR). Patients were treated with (4 - 6 cycles) and (6 - 8 cycles) respectively of alternating ABVD/COEP chemotherapy followed by involved-field radiation therapy (IFRT): 15 Gy for patients achieved complete response, and 25.5 Gy for those achieved a partial response. Results: 27 patients were IR and 27 patients were HR. There were 16 treatment failures; 5 patients had progressive disease; and 11 patients had a relapse. 9 patients died from their disease progression. The 5-year overall survival (OS) and event-free survival (EFS) rates (±SE) were 81.8% ± 5.7% and 71.8% ± 6.2% respectively. Multivariate analysis revealed that the only independent factor for inferior OS was radiotherapy. Conclusion: Treatment results of unfavourable HL patients in our study are satisfactory for with IR group but not for HR group who needs intensification of therapy. Radiotherapy is considered as a cornerstone in the treatment of the patients with unfavourable How to cite this paper: Ali, A.M., Mohamed, A.M., Ahmed, S., Abdallah, M., Alsaba, T.M. and Mansour, S. (2018) RiskAdapted, Combined-Modality Therapy for Unfavorable Pediatric Hodgkin Lymphom. Journal of Cancer Therapy, 9, 545-558. https://doi.org/10.4236/jct.2018.97046 Received: May 24, 2018 Accepted: July 7, 2018 Published: July 10, 2018 Copyright © 2018 by authors and Scientific Research Publishing Inc. This work is licensed under the Creative Commons Attribution International License (CC BY 4.0). http://creativecommons.org/licenses/by/4.0/ Open Access A. M. Ali et al. DOI: 10.4236/jct.2018.97046 546 Journal of Cancer Therapy criteria with better assessment of early responders needed by PET-CT to identify patients at risk for relapse.
Research Authors
Amany M. Ali1, Amira M. Mohamed1, Shimaa Ahmed2*, Mohamed Abdallah3, Tarek M. Alsaba4,
Saamer Mansour5
Research Department
Research Journal
Journal of Cancer Therapy
Research Member
Research Pages
pp. 545-558
Research Publisher
NULL
Research Rank
1
Research Vol
Vol. 9
Research Website
NULL
Research Year
2018

Multidisciplinary Management of Spinal Chordoma: Single Institution Study

Research Abstract
Introduction: Chordoma are rare, slowly growing, locally aggressive neoplasms of bone that arise from embryonic remnants of the notochord. This work aimed to evaluate the treatment results of a series of chordoma patients in our institute. More also, we try to clarify the importance of approaching such patients through a multidisciplinary team to maximize the oncologic and functional outcomes and to improve the patient's quality of life. Patients and Methods: This study was conducted at SECI, surgical department during a period of 6 years duration. Patients were treated through multi-disciplinary team specialists of our cancer institute. Surgery and postoperative radiation therapy was offered to all patients. Results: Results involves 8 patients with an average follow-up interval of 38.5 months. We had four cases of local recurrence which was salvaged with re-surgery and/or adjuvant radiotherapy. We had no postoperative motor neurologic deficit, with an excellent sphincter control in all patients. The 3-year survival rate in this study is 87.5%. Conclusions: Multi-disciplinary treatment approach for chordoma is fundamental to improve overall outcomes. Surgery continues to be the primary modality in the management of chordoma. Rates of local recurrence, as well as survival, appear to be dependent on the achievement of negative surgical margins. Patients who relapse locally may have a poor prognosis but both radiation and surgery can be used as salvage therapy.
Research Authors
Hamza HM, Eid S, Salah T, Farouk A, Kallaf MA, Mohamed AA5, Omar M
Research Department
Research Journal
SECI Oncology
Research Pages
NULL
Research Publisher
NULL
Research Rank
1
Research Vol
NULL
Research Website
NULL
Research Year
2017

Multidisciplinary Management of Spinal Chordoma: Single Institution Study

Research Abstract
Introduction: Chordoma are rare, slowly growing, locally aggressive neoplasms of bone that arise from embryonic remnants of the notochord. This work aimed to evaluate the treatment results of a series of chordoma patients in our institute. More also, we try to clarify the importance of approaching such patients through a multidisciplinary team to maximize the oncologic and functional outcomes and to improve the patient's quality of life. Patients and Methods: This study was conducted at SECI, surgical department during a period of 6 years duration. Patients were treated through multi-disciplinary team specialists of our cancer institute. Surgery and postoperative radiation therapy was offered to all patients. Results: Results involves 8 patients with an average follow-up interval of 38.5 months. We had four cases of local recurrence which was salvaged with re-surgery and/or adjuvant radiotherapy. We had no postoperative motor neurologic deficit, with an excellent sphincter control in all patients. The 3-year survival rate in this study is 87.5%. Conclusions: Multi-disciplinary treatment approach for chordoma is fundamental to improve overall outcomes. Surgery continues to be the primary modality in the management of chordoma. Rates of local recurrence, as well as survival, appear to be dependent on the achievement of negative surgical margins. Patients who relapse locally may have a poor prognosis but both radiation and surgery can be used as salvage therapy.
Research Authors
Hamza HM, Eid S, Salah T, Farouk A, Kallaf MA, Mohamed AA5, Omar M
Research Journal
SECI Oncology
Research Pages
NULL
Research Publisher
NULL
Research Rank
1
Research Vol
NULL
Research Website
NULL
Research Year
2017

Multidisciplinary Management of Spinal Chordoma: Single Institution Study

Research Abstract
Introduction: Chordoma are rare, slowly growing, locally aggressive neoplasms of bone that arise from embryonic remnants of the notochord. This work aimed to evaluate the treatment results of a series of chordoma patients in our institute. More also, we try to clarify the importance of approaching such patients through a multidisciplinary team to maximize the oncologic and functional outcomes and to improve the patient's quality of life. Patients and Methods: This study was conducted at SECI, surgical department during a period of 6 years duration. Patients were treated through multi-disciplinary team specialists of our cancer institute. Surgery and postoperative radiation therapy was offered to all patients. Results: Results involves 8 patients with an average follow-up interval of 38.5 months. We had four cases of local recurrence which was salvaged with re-surgery and/or adjuvant radiotherapy. We had no postoperative motor neurologic deficit, with an excellent sphincter control in all patients. The 3-year survival rate in this study is 87.5%. Conclusions: Multi-disciplinary treatment approach for chordoma is fundamental to improve overall outcomes. Surgery continues to be the primary modality in the management of chordoma. Rates of local recurrence, as well as survival, appear to be dependent on the achievement of negative surgical margins. Patients who relapse locally may have a poor prognosis but both radiation and surgery can be used as salvage therapy.
Research Authors
Hamza HM, Eid S, Salah T, Farouk A, Kallaf MA, Mohamed AA5, Omar M
Research Journal
SECI Oncology
Research Pages
NULL
Research Publisher
NULL
Research Rank
1
Research Vol
NULL
Research Website
NULL
Research Year
2017

Multidisciplinary Management of Spinal Chordoma: Single Institution Study

Research Abstract
Introduction: Chordoma are rare, slowly growing, locally aggressive neoplasms of bone that arise from embryonic remnants of the notochord. This work aimed to evaluate the treatment results of a series of chordoma patients in our institute. More also, we try to clarify the importance of approaching such patients through a multidisciplinary team to maximize the oncologic and functional outcomes and to improve the patient's quality of life. Patients and Methods: This study was conducted at SECI, surgical department during a period of 6 years duration. Patients were treated through multi-disciplinary team specialists of our cancer institute. Surgery and postoperative radiation therapy was offered to all patients. Results: Results involves 8 patients with an average follow-up interval of 38.5 months. We had four cases of local recurrence which was salvaged with re-surgery and/or adjuvant radiotherapy. We had no postoperative motor neurologic deficit, with an excellent sphincter control in all patients. The 3-year survival rate in this study is 87.5%. Conclusions: Multi-disciplinary treatment approach for chordoma is fundamental to improve overall outcomes. Surgery continues to be the primary modality in the management of chordoma. Rates of local recurrence, as well as survival, appear to be dependent on the achievement of negative surgical margins. Patients who relapse locally may have a poor prognosis but both radiation and surgery can be used as salvage therapy.
Research Authors
Hamza HM, Eid S, Salah T, Farouk A, Kallaf MA, Mohamed AA5, Omar M
Research Journal
SECI Oncology
Research Pages
NULL
Research Publisher
NULL
Research Rank
1
Research Vol
NULL
Research Website
NULL
Research Year
2017

Multidisciplinary Management of Spinal Chordoma: Single Institution Study

Research Abstract
Introduction: Chordoma are rare, slowly growing, locally aggressive neoplasms of bone that arise from embryonic remnants of the notochord. This work aimed to evaluate the treatment results of a series of chordoma patients in our institute. More also, we try to clarify the importance of approaching such patients through a multidisciplinary team to maximize the oncologic and functional outcomes and to improve the patient's quality of life. Patients and Methods: This study was conducted at SECI, surgical department during a period of 6 years duration. Patients were treated through multi-disciplinary team specialists of our cancer institute. Surgery and postoperative radiation therapy was offered to all patients. Results: Results involves 8 patients with an average follow-up interval of 38.5 months. We had four cases of local recurrence which was salvaged with re-surgery and/or adjuvant radiotherapy. We had no postoperative motor neurologic deficit, with an excellent sphincter control in all patients. The 3-year survival rate in this study is 87.5%. Conclusions: Multi-disciplinary treatment approach for chordoma is fundamental to improve overall outcomes. Surgery continues to be the primary modality in the management of chordoma. Rates of local recurrence, as well as survival, appear to be dependent on the achievement of negative surgical margins. Patients who relapse locally may have a poor prognosis but both radiation and surgery can be used as salvage therapy.
Research Authors
Hamza HM, Eid S, Salah T, Farouk A, Kallaf MA, Mohamed AA5, Omar M
Research Journal
SECI Oncology
Research Member
Research Pages
NULL
Research Publisher
NULL
Research Rank
1
Research Vol
NULL
Research Website
NULL
Research Year
2017

Multidisciplinary Management of Spinal Chordoma: Single Institution Study

Research Abstract
Introduction: Chordoma are rare, slowly growing, locally aggressive neoplasms of bone that arise from embryonic remnants of the notochord. This work aimed to evaluate the treatment results of a series of chordoma patients in our institute. More also, we try to clarify the importance of approaching such patients through a multidisciplinary team to maximize the oncologic and functional outcomes and to improve the patient's quality of life. Patients and Methods: This study was conducted at SECI, surgical department during a period of 6 years duration. Patients were treated through multi-disciplinary team specialists of our cancer institute. Surgery and postoperative radiation therapy was offered to all patients. Results: Results involves 8 patients with an average follow-up interval of 38.5 months. We had four cases of local recurrence which was salvaged with re-surgery and/or adjuvant radiotherapy. We had no postoperative motor neurologic deficit, with an excellent sphincter control in all patients. The 3-year survival rate in this study is 87.5%. Conclusions: Multi-disciplinary treatment approach for chordoma is fundamental to improve overall outcomes. Surgery continues to be the primary modality in the management of chordoma. Rates of local recurrence, as well as survival, appear to be dependent on the achievement of negative surgical margins. Patients who relapse locally may have a poor prognosis but both radiation and surgery can be used as salvage therapy.
Research Authors
Hamza HM, Eid S, Salah T, Farouk A, Kallaf MA, Mohamed AA5, Omar M
Research Department
Research Journal
SECI Oncology
Research Member
Research Pages
NULL
Research Publisher
NULL
Research Rank
1
Research Vol
NULL
Research Website
NULL
Research Year
2017

comparison between frequency ablation and chemical neurolysis of thoracic plainchant nerves for the management of abdominal cancer pain , randomized trial

Research Abstract
NULL
Research Authors
s.A.Amr , R.M. REyad ,A.h.Othman , M.F.mohamad , M.M .Mostfa ,N.H.Alieldin. , F.A.Hamed
Research Journal
EJP
Research Member
Research Pages
NULL
Research Publisher
NULL
Research Rank
1
Research Vol
NULL
Research Website
NULL
Research Year
2018

comparison between frequency ablation and chemical neurolysis of thoracic plainchant nerves for the management of abdominal cancer pain , randomized trial

Research Abstract
NULL
Research Authors
s.A.Amr , R.M. REyad ,A.h.Othman , M.F.mohamad , M.M .Mostfa ,N.H.Alieldin. , F.A.Hamed
Research Journal
EJP
Research Member
Samy Abdel Rahman Amr Erfan
Research Pages
NULL
Research Publisher
NULL
Research Rank
1
Research Vol
NULL
Research Website
NULL
Research Year
2018

Comparison Between the Effects of Intravenous Morphine,
Tramadol, and Ketorolac on Stress and Immune Responses
in Patients Undergoing Modified Radical Mastectomy

Research Abstract
Analgesics had been suspected of impairing various immune functions either directly or indirectly. Our primary objective was to compare the effects of intravenous (IV) morphine, tramadol, and ketorolac on stress and immune responses in patients who underwent modified radical mastectomy. Patients: Sixty patients randomly assigned to receive IV morphine 5mg (group M, n=20), tramadol 100mg (group T, n=20), or ketorolac 60mg (group K, n=20) at the end of surgery. Methods: Serum cortisol, prolactin were measured immediately, 40 minutes, and 24 hours postoperatively. Expressions of peripheral T lymphocytes (CD3+, CD3+CD4+, CD3+CD8+) and natural killer cells (CD3+, CD56+) were measured as percentages of total lymphocytes by flow cytometry immediately, 90 minutes, and 24 hours postoperatively. Results: After 40 minutes, cortisol level increased but prolactin decreased significantly (P=0.001), then both decreased after 24 hours (P=0.001) compared with baseline within the 3 groups. CD3, CD4, CD8, and CD56 significantly decreased at 90 minutes and 24 hours (Pr0.033) compared with baseline in the 3 groups. CD4, CD8, and CD56 significantly decreased in group M, compared with group T and K (Pr0.016) and CD3, CD8, and CD56 in group T compared with group K at 90 minutes (Pr0.024) postoperatively. After 24 hours, CD4, and CD8 decreased in group M compared with group T (Pr0.048) and CD4 and CD56 in groups M and T compared with group K (Pr0.049). Conclusions: IV morphine, tramadol, and ketorolac suppressed stress and immune responses. Ketorolac was the least immunosuppressive among the 3 drugs.
Research Authors
Mohamed A.-E.-M. Bakr, MD,* Samy A.-E. R. Amr, MD,w
Sahar A. Mohamed, MD,w Hosny B. Hamed, MD,z
Ahmad M. Abd EL-Rahman, MD,w Mohamed A. M. Mostafa, MD,w
and Fatma A. El Sherif, MDw
Research Journal
Clin J Pain
Research Member
Research Pages
pp. 889–897
Research Publisher
NULL
Research Rank
1
Research Vol
Vol. 32
Research Website
NULL
Research Year
2016
Subscribe to